NEOGENOMICS INC — Form 8-K
Filed July 20, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
NeoGenomics finalized a civil settlement with the DOJ on behalf of the OIG-HHS, resolving an investigation into consulting services provided to healthcare providers under its Laboratory Collaboration Initiative program. The company agreed to pay $9,813,260 plus 4.250% annual interest from January 16, 2026. The company had previously accrued a $11.2 million reserve; the settlement is below that reserve and does not constitute an admission of liability.
Why this rating
Settlement $9.8M is 1.4% of market cap; largely pre-accrued. Matter resolved; allows company to move forward. Immaterial to business trajectory.
See more from July 20, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.